Dr Vicky Price, president-elect of the Society for Acute Medicine, outlines why the Prime Minister's decision to abolish NHS ...

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new ...

Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that ...

Reckitt Benckiser Group PLC closed 5.02% below its 52-week high of £54.18, which the company achieved on March 7th.

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...

Reckitt--which houses Dettol, Harpic and Durex among its brands--said the judge ordered a retrial of a Missouri lawsuit that had found in October that subsidiary Mead Johnson wasn't liable for ...

BofA downgraded Reckitt Benckiser (RBGLY) to Neutral from Buy citing a lack of near-term catalysts and its preference for Unilever. Optimize ...

Berenberg analyst Fulvio Cazzol raised the firm’s price target on Reckitt Benckiser (RBGLY) to 5,920 GBp from 5,177 GBp and keeps a Hold rating ...

Reckitt said on Friday a circuit court in the United States had ruled that a new trial could be sought by plaintiffs in a ...

Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a ...

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as “non-core” in July as part of a ...